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Abstract
Background: The aim of the study was to investigate the effect of a vegan diet on the serum 
lipid profile with particular regard to the parameters characterizing the high-density lipoprotein 
(HDL) fractions in subjects without subclinical atherosclerosis, measured by carotid Doppler 
ultrasonography.
Methods and Results: Forty-two 23 to 38 year old subjects (21 omnivores and 21 vegans) 
participated in the study. Compared to the omnivores, the vegan subjects were characterized 
by lower parameters of lipid profile: total cholesterol (p < 0.001), low-density lipoprotein 
(LDL)-cholesterol (p < 0.001), non-HDL-cholesterol (p < 0.001), apolipoprotein B (apoB) 
(p < 0.001) and phospholipids (p < 0.01). Concentration of HDL-cholesterol was apparently 
similar between groups. Furthermore, the parameters which characterize HDL particles (con-
centration of apolipoproteins AI [apoAI] and AII, HDL-phospholipids, LpAI fraction and pre-
b1-HDL fraction) were not significantly different between omnivore and vegan subjects. The 
apoB/apoAI ratio in vegans was lower than in omnivores (p < 0.01). There was no difference 
between serum concentration of triacylglycerols between omnivores and vegans. The activity 
of paraoxonase-1 and 8-iso-prostaglandin F2a concentration were also not different between 
the study groups.
Conclusions: We suggest that a vegan diet may have a beneficial effect on serum lipid profile 
and cardiovascular protection, but it is not associated with changes in HDL composition.  
(Cardiol J 2016; 23, 2: 141–148)
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Introduction
Atherosclerosis is one of the leading causes 
of death throughout the world [1]. A crucial role 
in the pathogenesis of atherosclerosis is played 
by abnormalities in plasma lipid and lipoprotein 
metabolism [2]. The levels of serum lipids and 
lipoproteins are sensitive to the type and amount 
of fat and cholesterol in the diet. It has been shown 
in animal and human studies that the intake of 
a high amount of saturated fats and cholesterol is 
atherogenic [2, 3].
The main source of saturated fats and cho-
lesterol are products of animal origin, therefore it 
can be assumed that a vegan diet which excludes 
all products of animal origin could be beneficial in 
reducing the risk of atherosclerosis development. 
Indeed, some studies show that the use of a well-
balanced vegan diet can have a positive impact 
on cardiovascular risk [4, 5]. The possible health 
benefit from a vegan diet may be related to the low 
intake of saturated fats, higher intake of plant food 
components such as vegetable oils, vegetable pro-
teins, nuts, and fibers, which reduce serum lipids 
and may improve endothelial functions [6, 7]. Of 
particular importance may also be a greater supply 
of phytosterols, plant derived compounds similar to 
cholesterol which have lipid-lowering properties. 
Phytosterols reduce absorption of cholesterol in 
the digestive tract and influence lipoprotein me-
tabolism, which in turn may lead to a decrease in 
total cholesterol (TC) and low density lipoprotein 
(LDL) cholesterol (LDL-C) concentration [8, 9].
However, the impact of a vegan diet on other 
lipid-associated parameters is still ambiguous, for 
instance, a question still remains regarding the 
effect of a vegan diet on the quantity and quality 
of high density lipoproteins (HDL) [10]. HDL 
particles have an atheroprotective function and 
together with their main apolipoprotein, apoli-
poprotein AI (apoAI), play a key role in reverse 
cholesterol transport, removing excess cholesterol 
from peripheral tissues and delivering it to the 
liver. HDL particles also inhibit LDL oxidation, 
vascular inflammation and thrombosis. It is note-
worthy that HDL particles are heterogeneous in 
nature and not all HDL particles may be equally 
protective [11]. Therefore, concentration of HDL 
cholesterol (HDL-C) is not a reliable indicator of 
the anti-atherogenic potential of HDL particles. 
This suggests further investigation aimed to char-
acterize the quality of HDL particles such as pre-
b1-HDL, a precursor form of HDL, or the amount 
of HDL fraction containing apoAI and deprived of 
apoAII (LpAI) [12]. It also seems to be important 
to evaluate components of HDL other than choles-
terol lipids, for example phospholipids [13].
It is also suggested that a vegan diet, despite 
the large quantities of herbal antioxidants, may 
increase the risk of oxidative stress due to an insuf-
ficient supply of vitamin B12 and increased levels 
of homocysteine, which in turn may increase the 
oxidative modification of lipids and risk of athero-
sclerosis [14].
The purpose of the present study was to in-
vestigate the protective role of a vegan diet on the 
serum lipid profile with particular regard to the pa-
rameters characterizing the HDL fractions in sub-
jects without subclinical atherosclerosis, measured 
as carotid intima–media thickness (cIMT). We also 
investigated the effect of a vegan diet on the level of 
isoprostane (8-iso-prostaglandin F2a), a chemically 
stable lipid peroxidation product, and on the activ-
ity of paraoxonase-1 (PON-1), an HDL associated, 
antioxidant enzyme. Both of these parameters are 
not only oxidative balance markers, but have also 
been revealed as potential biofactors affecting the 
development of cardiovascular diseases [15, 16].
Methods
Subjects
All subjects participated voluntarily in the 
study and were 23 to 38 years old. Vegans were 
defined as those who do not eat any type of ani-
mal product, in other words, who exclude meat, 
dairy products and eggs at least from their diet. 
The subjects were on a vegan diet for at least 
10 months (mean ± standard deviation: 75 ± 44). 
All subjects before the start of a vegan diet had 
been on a vegetarian diet for at least 22 months 
(mean ± standard deviation: 128 ± 69).
Omnivores were defined as people who eat 
food of both plant and animal origin. Dietary assess-
ment was determined by investigators based on 
a self-reported questionnaire. Information on socio-
demographic characteristics, such as sex, age, 
anthropometric data, physical activity, lifestyle, 
dietary habits, physician-diagnosed diseases, and 
medical history were obtained through interviews. 
All participants were non-smoking, sedentary 
or moderately physically active (at least 2 times 
a week). Eighty percent of vegans participating in 
the study received a vitamin supplementation at 
least ones daily. In the omnivores group, vitamins 
supplementation concerned 28% of respondents. 
The eclusion criteria were: current use of pre-
scribed pharmaceuticals, intense physical activity 
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(up to 4 times a week), and a body mass index 
(BMI) greater than 25 kg/m2. 
The Scientific and Ethics Committee of the 
Medical University of Gdansk approved the study, 
and an informed written consent was obtained from 
each participant after the design and the objective 
of the study were explained.
Dietary assessment
Subjects were interviewed and the average 
of the three 24 h dietary recalls were used to 
estimate daily consumption of different nutrients. 
Diet was assessed using a validated interviewer-
administered quantitative food frequency ques-
tionnaire collecting information on portion size of 
commonly consumed food items. Standard portion 
size (e.g., tablespoon, ladle, and bowl expressed in 
[g]) and frequency (daily, weekly, monthly, never) 
were recorded. The energy value and contents of 
nutrients in daily food intake were appraised with 
the aid of a computer program (Diet-5) based on 
the current tables of values of nutritional products 
worked out at the National Food and Nutrition 
Institute in Warsaw, Poland [17]. The assessment 
of the participants’ eating habits was carried out 
using Polish recommendations [18]. Energy and 
macronutrient intakes as well as vitamin intakes 
were calculated by multiplying the daily frequency 
of specific foods by a standard portion and by the 
amount of nutrient present in each gram.
Clinical assessment and laboratory 
measurements
Total cholesterol, triacylglycerols (TAG), 
and phospholipids (PL) were measured by stan-
dard enzymatic colorimetric tests (Pointe Sci-
entific Poland) on a Multiskan™ GO Microplate 
Spectrophotometer (Thermo Scientific). HDLs 
were isolated by precipitation of apolipoprotein B 
(apoB)-containing lipoproteins with dextran sulfate 
50000/Mg2+ reagent and HDL-C was determined 
enzymatically. LDL-C concentration was calculated 
using the Friedewald formula (LDL = TC – HDL 
– TG/5). Non-HDL-cholesterol (nonHDL-C) was 
calculated according to the equation: nonHDL-C 
= TC – HDL-C.
Apolipoproteins B, AI and AII were assessed by 
nephelometric methods with antibodies from Dade 
Behring Marburg on a Behring laser nephelometer. 
LpAI was assayed by an electroimmunodiffusion 
(rocket) technique (Hydragel LpAI, Sebia, France). 
Pre-b1-HDL levels were measured by a sandwich 
enzyme immunoassay using MAB55201 [19]. 
Serum 8-iso-prostaglandin F2a concentration was 
measured by a sandwich enzyme-linked assay with 
a commercially available kit (Cayman Chemicals). 
PON1 activity was evaluated using two substrates: 
paraoxon for paraoxonase activity, and phenylac-
etate for arylesterase activity [20, 21].
Measurement of carotid artery  
intima–media thickness
An experienced cardiologist, blinded to the 
subject diet, performed all cIMT measures. The 
cIMT measurement was performed with the pa-
tient in the supine position with the neck slightly 
extended and turned 45° towards the opposite of 
the examined side to an L11 probe connected to 
a GE Vivid E9 BT12 cardiac ultrasound system. 
Right and left side common carotid artery images 
were obtained to measure cIMT by using three 
different angle views for each vessel: anterior, 
lateral and posterior. Optimal B-mode settings of 
gain, depth, focal zone placement, and compres-
sion were individually adjusted for each vessel 
to enhance arterial wall structures and image 
quality. cIMT was measured by a software pack-
age for automated border detection loaded on the 
system (EchoPAC, GE), and mean cIMT values 
were obtained.
Statistical analysis
Statistical analysis was performed using the 
Statistica software package (STATISTICA 10.0 
Statsoft Poland). To establish data distributions, the 
Shapiro-Wilk test was used. Continuous variables 
were expressed as mean ± standard deviation 
(SD) or median with 25th and 75th percentiles. Data 
analysis was performed using both parametric and 
non-parametric tests when appropriate. Compari-
son of unpaired data between the two groups was 
performed using the Student’s t-test for Gaussian 
variables and the Mann-Whitney-U test for non-
Gaussian ones. The p value obtained of less than 
0.05 was considered statistically significant.
Results
Forty-two subjects between 23 and 38 years 
participated in the study; 21 omnivores and 
21 vegans. The general and cardiovascular charac-
teristics of study subjects are shown in Table 1. The 
mean BMI and waist to hip ratio of omnivores and 
vegans were similar between groups and fell within 
the normal range. There was also no difference in 
systolic and diastolic blood pressure and heart rate 
between omnivore and vegan subjects. All meas-
urements of cIMT in vegan subjects were in the 
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Table 1. Baseline characteristics of the study groups.
Variable Omnivores (n = 21) Vegans (n = 21) P*
Gender: male/female 9/12 8/13 –
Age [years] 28 ± 4 28 ± 5 0.928
Body mass index [kg/m2] 21.1 ± 2 22.3 ± 2 0.814
Waist to hip ratio 0.84 ± 0.08 0.83 ± 0.08 0.659
Systolic BP [mm Hg] 123 ± 13 121 ± 9 0.565
Diastolic BP [mm Hg] 75 ± 10 73 ± 7 0.457
Heart rate [bmp] 78 ± 8 80 ± 7 0.393
IMT RCA [mm] 0.55 ± 0.07 0.53 ± 0.08 0.394
IMT LCA [mm] 0.54 ± 0.10 0.52 ± 0.09 0.499
Values are means ± standard deviation;*Student’s t-test. BP — blood pressure; IMT — intima-media thickness; LCA — left carotid artery;  
RCA — right carotid artery
Table 2. Daily intake of selected nutrients and vitamins in omnivores and vegans (median values and 
interquartile ranges [IQR]).
Daily intake of selected 
nutrients
Omnivores (n = 15) Vegans (n = 20) P*
Median IQR range DRIs Median IQR range DRIs
Energy [kcal] 1,914 1,528–2,306 46^ 2,036 1,830–2,178 15^ 0.962
Carbohydrate [g] 218 193–285 0^ 305 271–335 10^ 0.004
Protein [g] 82 62–97 12^ 56 48–66 10^ 0.003
Fiber [g] 18 12–24 75^^ 34 29–39 15^^ 0.002
Fat [g] 71 56–113 0^^^ 72 53–81 5^^^ 0.625
PUFAs [g] 8 5–16 68^ 15 11–18 35^ 0.016
Vitamin A [µg] 892 839–1,937 12^ 1,512 903–1,733 20^ 0.325
Vitamin E [µg] 10 6–14 37^^ 17 12–29 5^^ 0.003
Vitamin B1 [µg] 1.4 0.9–2.5 46^ 1.3 1.1–1.5 28^ 0.805
Vitamin B2 [µg] 1.5 1.2–1.9 25^ 1.4 1.0–2.9 42^ 0.860
Vitamin B6 [µg] 2.1 1.4–3.2 18^ 2.3 1.7–3.9 10^ 0.421
Vitamin B12 [µg] 2.9 2.2–6.1 6^ 44 11–93 0^ <0.001
Vitamin C [µg] 84 79–159 31^ 208 147–227 5^ 0.014
*P values from Mann-Whitney U tests for the assessment of significant differences between the median values; ^Estimated average requirement; 
^^Adequate intake; ^^^Dietary reference values; DRIs — dietary reference intakes; PUFAs — polyunsaturated fatty acids
normal range, i.e. below 0.9 mm, and did not sig-
nificantly differ from omnivore subjects (Table 1).
The median values of the estimated intake of 
energy and macronutrients of the omnivores and 
vegans are shown in Table 2. The total energy and 
fat intakes were similar for omnivores and vegans. 
The vegans consumed significantly more carbohy-
drates and the percentage of energy derived from 
carbohydrate in vegans was greater in comparison 
to the omnivores. However, 10% of vegan subjects 
were characterized by carbohydrate consumption 
under dietary reference intakes (DRI), but there 
were no omnivore subjects with carbohydrate 
consumption under DRI. Moreover, the vegan 
subjects consumed significantly more fibers and 
polyunsaturated fatty acids, but fewer proteins.
The median values of daily vitamin intake of 
both groups in comparison to DRIs are shown in 
Table 2. The vegan subjects consumed significantly 
more vitamin E, B12, and C than omnivore sub-
jects. Although vitamin A, B1, B2 and B6 intake 
was apparently similar in both groups, a higher 
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Table 3. Serum concentrations of high-density lipoprotein parameters in omnivores and vegans  
(median values and interquartile ranges [IQR]).
Omnivores (n = 21) Vegans (n =21) P*
Median IQR range Median IQR range
HDL-C [mg/dL] 45 36–50 45 42–52 0.326
HDL-PL [mg/dL] 90 77–98 86 77–99 1
ApoAI [g/L] 1.6 1.5–2.1 1.6 1.5–1.8 0.542
ApoAII [g/L] 0.37 0.34–0.39 0.38 0.32–0.39 0.509
LpAI [g/L] 0.53 0.36–0.75 0.44 0.39–0.49 0.188
preb1HDL [mg/L] 37 29–47 32 27–42 0.294
*P values from Mann-Whitney U tests for the assessment of significant differences between the median values; HDL-C — high density  
lipoprotein cholesterol; PL — phospholipids; apoAI and apoAII — apolipoproteins AI and AII
Figure 1. Serum concentrations of total cholesterol (TC; A), low-density lipoprotein cholesterol (LDL; B), non high 
density lipoprotein cholesterol (non-HDL-C; C), triacylglycerols (TAG; D), apolipoprotein B (apoB; E), phospholipids 
(PL; F) in vegans and omnivores. Values are presented as median; 25–75 percentile; 5–95 percentile and assessed by 
Mann-Whitney U test; *p < 0.001; **p < 0.01.
percentage of the vegans consumed less vitamin A 
and vitamin B2 than the DRIs.
Figure 1 and Table 3 show serum lipid concen-
trations in omnivores and vegans. The vegan sub-
jects were characterized by a lower concentration of 
TC (median: 140, range: 123–149 vs. 173, 154–196 
mg/dL, p < 0.001), LDL-C (median: 79, range: 68–91 
vs. 100, 87–133 mg/dL, p < 0.001), non-HDL-C 
(median: 98, range: 81–108 vs. 123, 105–148 mg/dL, 
p < 0.001), PL (median: 172, range: 165–194 vs. 
213, 186–224 mg/dL, p < 0.01), apoB (median: 0.54, 
range: 0.45–0.61 vs. 0.69, 0.61–0.83 g/L, p < 0.001), 
and apoB/apoA ratio (median: 0.31, range: 0.26–0.40 
vs. 0.39, 0.33–0.57, p < 0.01). Concentration of HDL-C 
was apparently similar between groups (Table 3). 
Additionally, the parameters which characterize HDL 
fraction (concentration of apolipoproteins AI and AII, 
HDL-PL, LpAI fraction, and pre-b1-HDL fraction) 
were not significantly different between omnivore 
and vegan subjects (Table 3). There was also no dif-
ference between the serum concentration of TAG of 
the omnivores and vegans (Fig. 1).
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Table 4. Paraoxonase-1 (PON-1) activities and 8-iso-prostaglandin F2a (8-iso-PGF2a) concentrations in 
omnivores and vegans (median values and interquartile ranges [IQR]).
Variable Omnivores (n = 21) Vegans (n = 21) P*
Median IQR range Median IQR range
Paraoxonase activity [U/L] 117 102–149 123 108–150 0.411
Arylesterease activity [kU/L] 115 110–135 122 92–136 0.906
8-iso-PGF2a [pg/mL] 114 91–150 104 83–135 0.526
 *P values from Mann-Whitney U tests for the assessment of significant differences between the median values
The activities of the antioxidant enzyme PON1, 
evaluated by paraoxonase and arylesterase activ-
ity, in omnivores and vegans are shown in Table 4 
and were not different between both groups. The 
concentration of 8-iso-prostaglandin F2a, an index 
of oxidative stress, was also not different between 
both groups (Table 4).
Discussion
In the present study, we have provided evi-
dence that the level and composition of HDL, an 
anti-atherogenic fraction of lipoproteins, are not 
affected in vegan subjects without subclinical ath-
erosclerosis, suggesting that the beneficial effect of 
a vegan diet for cardiovascular protection is hardly 
associated with HDL protective ability. Vascular 
remodeling of the carotid artery, clinically defined 
as intima-media thickening (cIMT), is an important 
predictive phenotype for human cardiovascular dis-
ease. There were no significant differences in cIMT 
measurements between omnivores and vegans in 
our study, and what is more, all measurements 
were within a normal range that could be explained 
by the relatively young age of subjects.
From a nutrient intake perspective, the vegan 
diet of the study subjects was rich in carbohydrates, 
polyunsaturated fatty acids and dietary fiber but 
relatively low in proteins. Furthermore, no differ-
ences were detected when comparing the energy 
and fat intake of omnivores and vegans. This is 
reflected by similar BMI and waist to hip ratio in 
the investigated groups (Table 1).
Our results demonstrate that vegans, in com-
parison to omnivore subjects, had significantly 
lower concentrations of TC, LDL-C, non-HDL-C, 
PL and apoB. In terms of TC and LDL-C concentra-
tions, this is well established because replacement 
of saturated fatty acids with polyunsaturated and 
monounsaturated fatty acids diminishes these 
parameters [22]. Additional higher contents of 
phytosterols in the vegan diet may cause a lipid-
lowering effect [8]. Our study also confirms recent 
reports observed by Bradbury et al. [23] in the 
large European population which show positive 
results in reduction of apoB and also a lower 
concentration of non-HDL-C in the vegan group. 
However, they have not evaluated the concentra-
tions of triglycerides and parameters associated 
with HDL particles [23].
A diet high in refined carbohydrates may in-
crease TAG, whereas high fiber content appears 
to have opposite results. However, our study 
demonstrated that subjects following vegan diet 
do not have significantly lower triacylglycerol con-
centration compared with those following diets that 
include animal products. Reports about the effects 
of a plant-based diet on TAG concentration are un-
equivocal. In Barnard et al.’s study [24], a low fat 
vegetarian diet led to an increase in serum TAG. 
Similar results were obtained when investigating 
the vegan population of pre-menopausal women 
[10]. Other studies show a reduction in the level 
of TAG during a vegan diet [25]. In our study, we 
did not notice differences either in the concentra-
tions of TAG or in the level TAG/HDL-C, which 
seems to be a more reliable predictor of myocardial 
infarctions [26, 27]. It is possible that other factors, 
e.g. environmental and genetic, may have an impact 
on TAG metabolism since it has been noticed that 
the effect of diet had greater benefits in subjects 
from developing countries [28].
HDL particles act as potential protectors 
against arterial disease mainly through their abil-
ity to promote cholesterol efflux from macro-
phages in the artery wall. However, HDLs have 
several additional protective properties that are 
independent of their involvement in cholesterol 
metabolism, among others they have properties 
that reduce oxidation, vascular inflammation and 
thrombosis. There is substantial evidence that the 
anti-atherogenic effect of HDL depends not only 
on its concentration expressed as HDL-C but also 
the quantitative and qualitative composition of the 
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lipoproteins. Previously published results of stud-
ies do not provide a clear answer to the question of 
how, if at all, a vegan diet influences HDL particles. 
Some researchers have shown the lowering effects 
of a vegan diet on HDL-C concentration, which 
may impair its cardioprotective character [10, 
29]. We did not find a significant lowering effect 
of vegan diet on HDL-C concentration (Table 3). 
Furthermore, we measured parameters other than 
HDL-C characterizing this fraction of lipoproteins. 
Concentrations of the apoAI and apoAII in vegan 
subjects were not different from these of omnivore 
subjects. Similarly, we did not notice differences in 
concentration of HDL particles containing apoAI 
but not apoAII (LpAI) between omnivores and 
vegans. Neither did we find significant differences 
in concentration of pre-b1-HDL, a precursor of 
HDL particles. Similar levels of major HDL apoli-
poproteins, LpAI fraction and pre-b1-HDL fraction 
suggest that a vegan diet, in our study subjects, 
significantly affects neither serum HDL-C nor 
HDL composition. Some investigators postulated 
that the apoB/apoAI ratio may be useful in clinic 
as a convenient biomarker in metabolic syndrome 
predicting. We have shown that the apoB/apoAI ra-
tio in vegan subjects was lower than in omnivores, 
confirming that a vegan diet may have a protective 
effect for metabolic syndrome development [30].
Metabolic syndrome and cardiovascular disor-
ders are characterized by a disturbance in oxidative 
balance. It is suggested that a vegan diet as an 
extreme form of diet, despite the large quantities 
of herbal antioxidants, may increase the risk of 
oxidative stress due to the insufficient supply of 
vitamin B12 and increased levels of homocysteine, 
which in turn may increase the oxidative modifica-
tion of lipids and risk of atherosclerosis [16]. The 
present data do not confirm this hypothesis, though 
this may result from different vitamin supplementa-
tion in the study populations. Analyzing the food 
intake questionnaire, we concluded that all vegan 
subjects included in our study used at least one 
vitamin preparation and daily intake of E, B12, 
and C vitamins by our vegan group was higher 
than in omnivores. These results suggest that 
a vegan diet in our subjects meets their nutritional 
needs. This suggestion is supported by the results 
of PON-1 activity and concentration of isoprostane 
in blood. We did not notice the effects of diet on 
PON-1 activity either in paraoxonase or in aryloes-
terase activity. We also showed no differences in 
8-iso-prostaglandin F2a concentration, which is 
a sensitive parameter of oxidative stress and lipid 
peroxidation.
Conclusions
In conclusion, the findings of this study have 
shown that a vegan diet did not change the param-
eters expressly connected with HDL fraction. We 
also did not show the effect of diet on lipoprotein 
peroxidation markers. Lower concentration of 
TC, LDL-C as also a lower ratio of apoB/apoAI 
suggest that there could be a beneficial effect of 
a vegan diet for cardiovascular protection. However, 
because vegan diet is an extreme form of diet 
we should be aware that its long-term effect on 
health is dependent upon adequate delivery of all 
the needed micronutrients which can be a serious 
challenge.
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